NANODESK, LLC

Biotech · Private

Software platform for designing DNA origami nanostructures

Grants
$305K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Software for Collaborative End-to-End Development of DNA Nanostructures$305,000
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1257Satellite Biosciences, Inc.—$101M
1258GPN THERAPEUTICS, INC.——
1259AYTU BIOSCIENCE, INC—$26M
1260NANODESK, LLC——
1261CODOMAX INC.——
1262Young Biopharma, LLC——
1263Proteovant Therapeutics——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.